Handbook of Complementary, Alternative, and Integrative Medicine

Name: Handbook of Complementary, Alternative, and Integrative Medicine | Education, Practice and Research Volume 4: Disease Focused Efficacy and Safety Profiles: Cardiovascular, Endocrine, Respiratory, Gastrointestinal, Renal, Arthritis and Neurology Disorders
Brand: CRC Press
Price: 270.99 EUR
Availability: OnlineOnly

Education, Practice and Research Volume 4: Disease Focused Efficacy and Safety Profiles: Cardiovascular, Endocrine, Respiratory, Gastrointestinal, Renal, Arthritis and Neurology Disorders

Yaser Mohammed Al-Worafi(Herausgeber*in)

CRC Press

1. Auflage

Erschienen am 7. Mai 2025

714 Seiten

E-Book

PDF mit Adobe-DRM

Systemvoraussetzungen

978-1-040-32671-8 (ISBN)

270,99 €inkl. 7% MwSt.

Systemvoraussetzungen

für PDF mit Adobe-DRM

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

Weitere Details

Weitere Ausgaben

Person

Prof. Yaser Mohammed Al-Worafi is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, UAE (Previously known as Ajman University). He graduated with a bachelor's degree in Pharmacy (BPharm) from Sana'a University, Yemen, and obtained a Master's and PhD in Clinical Pharmacy from the Universiti Sains Malaysia (USM), Malaysia. Prof. Yaser has many postgraduate program certificates including Training to Teach in Medicine 2023 from Harvard Medical School, Harvard University; Contemporary Approaches to University Teaching from The Council of Australasian University Leaders in Learning and Teaching (CAULLT). Prof. Yaser is a fellow of the Royal Society of Public Health, UK. He has over 20 years of experience in education, practice, and research in Yemen, Saudi Arabia, the United Arab Emirates, and Malaysia. He has held various academic and professional positions including Deputy Dean for Medical Sciences College; PharmD program director, Head of Clinical Pharmacy/Pharmacy Practice department; Head of Teaching & Learning committee, Head of Training committee, head of curriculum committee, and other committees. He has authored over 100 peer-reviewed papers in international journals, book chapters, and edited more than 30 books and 1500 book chapters by Springer, Elsevier, Taylor & Francis, USA. Prof.Yaser has supervised/co-supervised PhD (3, one finished), Master's (27, 20 Finished), PharmD (33-finished), and B-Pharm (More than 120, 100 Finished) students. He is a reviewer for eight recognized international peer-reviewed journals. Prof. Yaser taught, prepared, designed, and wrote many pharmacy programs for many universities including the Master of Clinical Pharmacy/Pharmacy Practice program; PharmD program and BPharm program; internship/clerkships for Master, PharmD, and BPharm programs; more than 30 courses related to Clinical Pharmacy, Pharmacy Practice, Social Pharmacy and Patients' Care.

Herausgeber*in

Yaser Mohammed Al-Worafi

University of Science and Technology of Fujairah, United Arab Emirates

Inhalt

Introduction. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Concepts. Part I. Cardiovascular Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Hypertension. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Hyperlipidemia. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Angina and Myocardial Infections. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Heart Failure. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Arrhythmias. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Thrombosis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Stroke. Part II Endocrine Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Diabetes Mellitus. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Thyroid disorders. Part III. Respiratory Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Asthma. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Chronic Obstructive Pulmonary Diseases (COPD). Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Rhinitis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Cystic Fibrosis. Part IV. Gastrointestinal Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Constipation. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Diarrhea. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Peptic Ulcer. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Inflammatory Bowel Disease. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Nausea & Vomiting. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Gastroesophageal Reflux Disease. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Liver diseases. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Pancreatitis. Part V. Renal Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy): kidney diseases. Evidence-based Complementary, Alternative and Integrated Medicine & (Safety): kidney diseases. Part VI. Arthritis Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Gout and Hyperuricemia. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Osteoporosis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Rheumatoid Arthritis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Osteoarthritis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Connective Tissue Disorders. Part VII. Neurological Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Epilepsy. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Headaches. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Pain. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Parkinson disease. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Multiple Sclerosis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Alzheimer's Disease.

Systemvoraussetzungen

Als PDF speichern Als Link merken